architecture documents, as well as Epics, Features and stories for our development teams. Main responsibilities : Solution... Architecture Designs Technology Selection Decisions Security & Operational Design Stakeholder Management Who...
and consolidation activities in Europe. Defining/Validating the overall detailed architecture of new services and network features... service. Assessing Fixed Access Engineering, analyzing the UK Market requirements and current architecture to deliver...
We're looking for an Azure DevOps Architect to work on the strategy and architecture of the platform and live... and architecture of everything DevOps and Azure. Essential Skills 4 years+ experience in an operational role with a cloud platform...
. You are expected to be involved in the design and architecture of the solutions while also focusing on the entire SDLC lifecycle stages..., and portfolio operations Delivers data pipeline and architecture solutions that can be leveraged across multiple businesses...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »